TuHURA Biosciences (HURA) Earnings Date & Reports

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HURA is expected to report earnings to fall 4.29% to -13 cents per share on November 13

TuHURA Biosciences HURA Stock Earnings Reports

Q3'26

Est.

$-0.13

Q2'26

Missed

by $0.04

Q1'26

Missed

by $0.04

Q4'25

Beat

by $0.02

Q2'25

Missed

by $0.04

The last earnings report on August 18 showed earnings per share of -14 cents, missing the estimate of -10 cents. With 55.82K shares outstanding, the current market capitalization sits at 130.64M.

View a ticker or compare two or three

HURA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for HURA